TENOFOVIR PRODRUG AND PHARMACEUTICAL USES THEREOF Russian patent published in 2018 - IPC C07F9/6561 A61K31/675 A61P31/12 

Abstract RU 2664534 C9

FIELD: chemistry.

SUBSTANCE: invention relates to a compound for the treatment of viral diseases of general formula (I), an enantiomer, diastereomer or a pharmaceutically acceptable salt thereof: , where R1 and R2 are C1-6-alkyl, respectively, or R1 and R2 together with the attached carbon atom form C3-7-cycloalkyl, R3 is H or C1-6-alkyl, Ar represents a substituted or unsubstituted C6-10-aryl, or 6-10-membered heteroaryl, wherein the substituent is independently selected from alkyl, alkenyl, alkynyl, alkoxy, alkylthio, alkylamino, halogen, thiol, hydroxyl, nitro, cyano, C3-7-cycloalkyl, C1-6-aryl, 6-10 membered heteroaryl, including O, S or N as a ring atom.

EFFECT: novel effective antiviral compounds and compositions based thereon have been proposed, that are useful for the treatment of viral infections and for the preparation of medicaments for the treatment of viral infections such as HIV and hepatitis B.

11 cl, 4 tbl, 14 ex

Similar patents RU2664534C9

Title Year Author Number
PRODRUG BASED ON TENOFOVIR MONOBENZYL ESTER PHOSPHAMIDE, A METHOD FOR PRODUCTION THEREOF AND USE THEREOF 2016
  • Wang, Guocheng
  • Wu, Huimin
RU2719594C2
NUCLEOTIDES INCLUDING N-[(S)-1-CYCLOBUTOXYCARBONYL]PHOSPHORAMIDATE FRAGMENT, THEIR ANALOGS AND THEIR APPLICATION 2017
  • Aleksandr Vasilevich Ivashchenko
  • Mitkin Oleg Dmitrievich
RU2659388C1
ANELLATED 9-HYDROXY-1,8-DIOXO-1,3,4,8-TETRAHYDRO-2H-PYRIDO[1,2-A]PYRAZINE-7-CARBOXAMIDES - INTEGRASE INHIBITORS, METHODS FOR PREPARING AND USING THEREOF 2019
  • Ivashchenko Andrej Aleksandrovich
  • Ivashchenko Aleksandr Vasilevich
  • Mitkin Oleg Dmitrievich
  • Savchuk Nikolaj Filippovich
RU2717101C1
β-D-2ʹ-DEOXY-2ʹ-α-FLUORO-2ʹ-β-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR TREATMENT OF DISEASES CAUSED BY HCV 2016
  • Sommadossi, Jean-Pierre
  • Moussa, Adel
RU2764767C2
PYRIDAZINE DERIVATIVE INHIBITOR, METHOD OF ITS PREPARATION AND ITS USE 2020
  • Gao Peng
  • Zeng Mi
  • Tan Songliang
  • Sun Guangjun
  • Wang Shaobao
  • Xiu Wenhua
  • Bao Rudi
RU2807611C2
MKK4 PROTEIN KINASE INHIBITORS FOR STIMULATION OF LIVER REGENERATION OR REDUCTION OR PREVENTION OF HEPATOCYTE DEATH 2019
  • Praefke, Bent
  • Klefekorn, Filip
  • Zelig, Roland
  • Albrekht, Volfgang
  • Laufer, Shtefan
RU2788000C2
HETEROARYL PIPERAZINE DERIVATIVE, METHOD FOR ITS PREPARATION AND APPLICATION IN MEDICINE 2018
  • Li, Sin
  • Khe, Vej
  • Chen, Yan
  • Khe, Fen
  • Tao, Vejkan
RU2745431C1
LIGAND-DRUG CONJUGATE OF EXATECAN ANALOGUE, ITS PRODUCTION METHOD AND ITS USE 2019
  • Syuj, Tszyanyan
  • Chzhan, In
  • Tsaj, Syaofen
  • Tsyuj, Bolej
  • Lyan, Tszindun
  • Chzhan, Lyanshan
  • Khe, Fen
  • Tao, Vejkan
RU2793316C2
SUBSTITUTED AMINO SIX-MEMBER SATURATED HETEROALICYCLES AS LONG-ACTING DPP-IV INHIBITORS 2016
  • Xu, Xinhe
  • Shen, Yu
  • Xiao, Dengming
  • Luo, Hong
  • Peng, Yong
  • Han, Yongxin
  • Zhang, Aiming
  • Yang, Ling
RU2720488C2
QUINOXALINE-CONTAINING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS 2008
  • Gaj Junkhua
  • Or Jat Sun'
  • Van Chzheh
RU2493160C2

RU 2 664 534 C9

Authors

Chzhan Fuyao

Vej Dun

Dates

2018-08-20Published

2013-07-10Filed